Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT – Research Report), Intercept Pharma (ICPT – Research Report) and ...

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

Detailed price information for Alpha Teknova Inc (TKNO-Q) from The Globe and Mail including charting and trades.

14 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ: ... Analyst Expectations For Sarepta Therapeutics's Future November 25, 2024 — 08:01 am EST.

Explore Sarepta Therapeutics analyst ratings and price targets (NASDAQ:SRPT) on Benzinga. Stay updated on expert opinions and forecasts for SRPT stock.

Sarepta reports a second fatal case of acute liver failure linked to Elevidys. Analyst cuts Sarepta’s rating due to uncertain safety and future revenue potential. A new wave of value and ...

Sarepta Therapeutics (SRPT) Tumbles 44% W/W as Analyst Cuts Price Target by 63%. A laboratory technician in a white coat holding a microscope and examining a vial of biopharmaceuticals.

Stay up-to-date on Wall Street's latest analyst calls, stock downgrades, and upgrades for major companies like Sarepta, Cisco, and more.

A key issue, to hear the analyst team tell it, is what happens beyond Catalent’s current fiscal year. Sarepta already has a “meaningful supply” of Elevidys doses on hand from the last few ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report), AlloVir (ALVR – Research Report) and Bristol-Myers Squibb (BMY ...

The analyst noted elevated soft costs in the U.S. solar market, including higher sales and marketing expenses, permitting fees, and overheads, with U.S. residential system costs in the $2.25-$3.25 ...